Lynx1 Capital Management

Lynx1 Capital Management as of June 30, 2024

Portfolio Holdings for Lynx1 Capital Management

Lynx1 Capital Management holds 17 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Merus N V (MRUS) 25.9 $71M 1.2M 59.17
Stoke Therapeutics (STOK) 25.4 $70M 5.2M 13.51
Gh Research Ordinary Shares (GHRS) 16.8 $46M 4.0M 11.66
C4 Therapeutics Com Stk (CCCC) 11.5 $32M 6.9M 4.62
Tscan Therapeutics (TCRX) 11.1 $31M 5.2M 5.85
Cullinan Oncology (CGEM) 2.4 $6.6M 377k 17.44
Allogene Therapeutics (ALLO) 1.9 $5.2M 2.2M 2.33
Longboard Pharmaceuticals In (LBPH) 1.6 $4.5M 167k 27.03
Passage Bio (PASG) 1.5 $4.0M 5.1M 0.79
Cabaletta Bio (CABA) 1.3 $3.7M 492k 7.48
Ibio Con New (IBIO) 0.2 $508k 241k 2.11
Bionomics Ads (BNOX) 0.2 $460k 600k 0.77
Pieris Pharmaceuticals Com New (PIRS) 0.2 $427k 44k 9.81
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) 0.1 $177k 9.5k 18.67
Centessa Pharmaceuticals Sponsored Ads (CNTA) 0.1 $157k 17k 9.03
Korro Bio (KRRO) 0.0 $129k 3.8k 33.87
Vyne Therapeutics (VYNE) 0.0 $32k 16k 1.97